Clinical Trial

Biochemical Evaluation of Periodontal Effects of Orthodontic Treatment with Aligners

Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated October 17, 2024 (before its estimated October 30, 2024 completion). Its status may not reflect the trial's current state.
Summary
The aim of this study was to determine the effect of orthodontic treatment with aligner on changes in osteoprotegerin (OPG) and receptor activator of NF-κB ligand (RANKL) levels in saliva samples and to investigate the possible relationship between periodontal clinical parameters. Materials and Methods: A total of 25 (n=25) saliva samples were taken from systemically healthy non-smoking individuals who were planned to receive orthodontic treatment with aligner before treatment. Whole mouth clinical periodontal measurements including probing depth (PD), clinical attachment level (CAL), bleeding on probing (BOP), gingival index (GI) and plaque index (PI) were also recorded and repeated at 1 and 3 months. Enzyme-linked immunosorbent assay (ELISA) was used to determine OPG and RANKL levels in biological samples.
Trial Details
NCT Number NCT06646705
Lead Sponsor Izmir Katip Celebi University
Conditions Aligner Treatment
Enrollment 25 participants
Start Date 2023-04-06
Primary Completion 2024-10-30 (estimated)
Study Completion 2024-12-30 (estimated)
Updated on ClinicalTrials.gov 2024-10-17